Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar for Chronic Antibody-mediated Rejection in Kidney Transplant
NCT02546492Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Aug 2016
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in chronic antibody-mediated rejection (cAMR), sponsored by University of Maryland, Baltimore. Started Aug 2016; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
chronic antibody-mediated rejection (cAMR)
Beyond the preview
Go deeper on NCT02546492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546492.